The North America anticholinergic drugs market faces continued emphasis on medication safety, especially for older adults and patients taking multiple prescriptions. Manufacturers may find opportunities in improved formulations and patient-focused delivery options, while clinical demand remains influenced by efficacy, tolerability, and prescribing guidelines. The anticholinergic drugs market...